Translational research on HGF: A phase I/II study of recombinant human HGF for the treatment of fulminant hepatic failure

Hepatology Research

Volumn 38, Issue SUPPL. 1, 2008, Pages

  Ido, Akio ^a,b   Moriuchi, Akihiro ^a   Marusawa, Hiroyuki ^c   Ikeda, Kazuki ^c   Numata, Masatsugu ^b   Yamaji, Naohisa ^b   Setoyama, Hitoshi ^a   Ida, Hiroshi ^c   Oketani, Makoto ^a   Chiba, Tsutomu ^c   Tsubouchi, Hirohito ^a,b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b Translational Research Center   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Fulminant hepatic failure; Hepatocyte growth factor; Liver regeneration; Translational research

Indexed keywords

ALBUMIN; RECOMBINANT SCATTER FACTOR; SCATTER FACTOR RECEPTOR;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; BRAIN DISEASE; CARDIOTOXICITY; CLINICAL TRIAL; CONFERENCE PAPER; DEATH; DRUG EFFICACY; DRUG HALF LIFE; DRUG PURIFICATION; DRUG RESEARCH; DRUG SAFETY; HUMAN; LIVER FAILURE; LIVER REGENERATION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MEDICAL RECORD; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; SINGLE DRUG DOSE; STRUCTURE ANALYSIS; SYSTOLIC BLOOD PRESSURE; UNSPECIFIED SIDE EFFECT; URINARY EXCRETION;

EID: 58049086066     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00432.x     Document Type: Conference Paper

References (34)

1. Nakayama H, Tsubouchi H, Gohda E etal. Stimulation of DNA synthesis in adult rat hepatocyte in primary culture by sera from patients with fulminant hepatic failure. Biomed Res 1985; 6: 231-7.
2. Gohda E, Tsubouchi H, Nakayama H et al. Purification and partial characterization of hepatocyte growth factor from plasma of patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414-19.
3. Miyazawa K, Tsubouchi H, Naka D et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989; 163: 967-73.
4. Yoshiyama Y, Arakaki N, Naka D etal. Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor. Biochem Biophys Res Commun 1991; 175: 660-7.
5. Miyazawa K, Shimomura T, Kitamura A, Kondo J, Morimoto Y, Kitamura N. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII. J Biol Chem 1993; 268: 10024-8.
6. Gohda E, Nakamura S, Yamamoto I, Minowada J. Hepatocyte growth factor-pleiotropic cytokine produced by leukemia cells. Leuk Lymphoma 1995; 19: 197-205.
7. Weidner KM, Arakaki N, Hartmann G et al. Evidence for the identity of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 7001-5.
8. Bussolino F, Di Renzo MF, Ziche M et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 119: 629-41.
9. Fujiwara K, Nagoshi S, Ohno A et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993; 18: 1443-9.
10. Moriuchi A, Hirono S, Ido A etal. Additive and inhibitory effects of simultaneous treatment with growth factors on DNA synthesis through MAPK pathway and G1 cyclins in rat hepatocytes. Biochem Biophys Res Commun 2001; 280: 368-73.
11. Moriuchi A, Ido A, Nagata Y et al. A CRE and the region occupied by a protein induced by growth factors contribute to up-regulation of cyclin D1 expression in hepatocytes. Biochem Biophys Res Commun 2003; 300: 415-21.
12. Ishii T, Sato M, Sudo K etal. Hepatocyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomized rats. J Biochem 1995; 117: 1105-12.
13. Hasuike S, Ido A, Uto H et al. Hepatocyte growth factor accelerates the proliferation and differentiation of hepatic oval cells in a 2-acetylaminofluorene/partial hepatectomy model in rats. J Gastroenterol Hepatol 2005; 20: 1753-61.
14. Shiota G, Kunisada T, Oyama K et al. In vivo transfer of hepatocyte growth factor gene accelerates proliferation of hepatic oval cells in a 2-acethlaminofluorene/partial hepatectomy model in rats. FEBS Lett 2000; 470: 325-30.
15. Okano J, Shiota G, Kawasaki H. Protective action of hepatocyte growth factor for liver injury caused by D-galactosamine in transgenic mice. Hepatology 1997; 26: 1241-9.
16. Kosai K, Matsumoto K, Nagata S, Tsujimoto Y, Nakamura T. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor. Biochem Biophys Res Commun 1998; 244: 683-90.
17. Masunaga H, Fujise N, Shiota A et al. Preventive effects of the deleted form of hepatocyte growth factor against various liver injuries. Eur J Pharmacol 1998; 342: 267-79.
18. Kosai K, Matsumoto K, Funakoshi H, Nakamura T. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 1999; 30: 151-9.
19. Nomi T, Shiota G, Isono M, Sato M, Kawasaki H. Adenovirus-mediated hepatocyte growth factor gene transfer prevents lethal liver failure in rats. Biochem Biophys Res Commun 2000; 278: 338-43.
20. Ozaki M, Haga S, Zhang HQ, Irani K, Suzuki S. Inhibition of hypoxia/ reoxygenation-induced oxidative stress in HGF-stimulated antiapoptotic signaling: Role of PI3-K and Akt kinase upon rac1. Cell Death Differ 2003; 10: 508-15.
21. Wang X, DeFrances MC, Dai Y et al. A Mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell 2002; 9: 411-21.
22. Kusumoto K, Ido A, Moriuchi A et al. Repeated intravenous injection of recombinant human hepatocyte growth factor ameliorates liver cirrhosis but cause albuminuria in rats. Int J Mol Med 2006; 17: 503-9.
23. Yasuda H, Imai E, Shiota A, Fujise N, Morinaga T, Higashio K. Antifibrogenic effect of a deletion variant of hepatocyte growth factor on liver fibrosis in rat. Hepatology 1996; 24: 636-42.
24. Matsuda Y, Matsumoto K, Yamada A et al. Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/ cirrhosis. Hepatology 1997; 26: 81-9.
25. Ueki T, Kaneda Y, Tsutsui H et al. Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nat Med 1999; 5: 226-30.
26. Sato M, Kakubari M, Kawamura M, Sugimoto J, Matsumoto K, Ishii T. The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochem Pharmacol 2000; 59: 681-90.
27. Oe S, Fukunaka Y, Hirose T, Yamaoka Y, Tabata Y. A trial on regeneration therapy of rat liver cirrhosis by controlled release of hepatocyte growth factor. J Control Release 2003; 88: 193-200.
28. Xue F, Takahara T, Yata Y etal. Hepatocyte growth factor gene therapy accelerates regeneration in cirrhotic mouse livers after hepatectomy. Gut 2003; 52: 694-700.
29. Matsuno Y, Iwata H, Umeda Y etal. Hepatocyte growth factor gene transfer into the liver via the portal vein using electroporation attenuates rat liver cirrhosis. Gene Ther 2003; 10: 1559-66.
30. Ido A, Moriuchi A, Kim I et al. Pharmacokinetic study of recombinant human hepatocyte growth factor administered in a bolus intravenously or via portal vein. Hepatol Res 2004; 30: 175-81.
31. Santoni-Rugiu E, Preisegger KH, Kiss A et al. Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model. Proc Natl Acad Sci USA 1996; 93: 9577-82.
32. Sakata H, Takayama H, Sharp R, Rubin JS, Merlino G, LaRochelle WJ. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ 1996; 7: 1513-23.
33. Takayama H, LaRochelle WJ, Sharp R et al. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci USA 1997; 94: 701-6.
34. Nakanishi C, Moriuchi A, Ido A et al. Effect of hepatocyte growth factor on endogenous hepatocarcinogenesis in rats fed a choline-deficient L-amino acid-defined diet. Oncol Rep 2006; 16: 25-31.